Azenta, Inc.
General ticker "AZTA" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $1.3B (TTM average)
Azenta, Inc. follows the US Stock Market performance with the rate: 16.9%.
Estimated limits based on current volatility of 3.8%: low 34.64$, high 37.35$
Factors to consider:
- Total employees count: 3000 (-9.1%) as of 2025
- US accounted for 61.5% of revenue in the fiscal year ended 2025-09-30
- Top business risk factors: Economic downturns and volatility, Public health crises, Climate change and natural disasters, Currency fluctuations, ESG risks
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [21.62$, 36.07$]
- 2026-09-30 to 2027-09-30 estimated range: [23.30$, 37.88$]
Financial Metrics affecting the AZTA estimates:
- Positive: with PPE of 55.8 at the end of fiscal year the price was neutral
- Positive: 4.90 < Operating cash flow per share per price, % of 5.33
- Positive: -13.52 < Operating profit margin, % of -4.33
- Negative: Industry operating cash flow per share per price (median), % of 1.48 <= 3.66
- Negative: Investing cash flow per share per price, % of -6.68 <= -4.49
- Negative: Industry earnings per price (median), % of 0 <= 0
- Negative: Shareholder equity ratio, % of 83.85 > 81.92
- Negative: negative Industry operating income (median)
Short-term AZTA quotes
Long-term AZTA plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | $665.07MM | $573.45MM | $593.82MM |
| Operating Expenses | $738.20MM | $603.43MM | $620.66MM |
| Operating Income | $-73.13MM | $-29.98MM | $-26.84MM |
| Non-Operating Income | $42.69MM | $10.86MM | $19.70MM |
| R&D Expense | $33.96MM | $31.52MM | $30.39MM |
| Income(Loss) | $-30.43MM | $-19.12MM | $-7.14MM |
| Taxes | $-17.55MM | $5.24MM | $-31.60MM |
| Other Income(Loss) | $-1.37MM | $-140.53MM | $-80.22MM |
| Net Income(Loss)* | $-14.26MM | $-164.90MM | $-55.76MM |
| Stockholders Equity | $2,534.50MM | $1,767.85MM | $1,726.99MM |
| Inventory | $128.20MM | $115.26MM | $74.96MM |
| Assets | $2,885.72MM | $2,100.26MM | $2,059.58MM |
| Operating Cash Flow | $5.83MM | $49.74MM | $72.18MM |
| Capital expenditure | $39.44MM | $37.39MM | $33.86MM |
| Investing Cash Flow | $431.38MM | $224.74MM | $-90.46MM |
| Financing Cash Flow | $-840.46MM | $-659.21MM | $-9.59MM |
| Earnings Per Share** | $-0.22 | $-3.10 | $-1.22 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.